FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
This Quarter Return
+20.37%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$20.2B
AUM Growth
+$20.2B
(+8.8%)
Cap. Flow
-$834M
Cap. Flow
% of AUM
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
41.49%
Holding
507
New
64
Increased
168
Reduced
186
Closed
63
Top Buys
| 1 |
Micron Technology
MU
|
$152M |
| 2 |
Stryker
SYK
|
$102M |
| 3 |
Netflix
NFLX
|
$92.2M |
| 4 |
Mobileye
MBLY
|
$73.1M |
| 5 |
Citigroup
C
|
$69.2M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$206M |
| 2 |
UnitedHealth
UNH
|
$136M |
| 3 |
Apple
AAPL
|
$106M |
| 4 |
Transmedics
TMDX
|
$99.2M |
| 5 |
ServiceNow
NOW
|
$82.3M |
Sector Composition
| 1 | Technology | 39.23% |
| 2 | Healthcare | 17.27% |
| 3 | Consumer Discretionary | 11.73% |
| 4 | Communication Services | 11.02% |
| 5 | Industrials | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
NeoGenomics
NEO
$1.06B
| $36.8M | 0.18% |
2,339,766
+463,936
| +25% | +$7.29M |
|
102
Veeva Systems
VEEV
$44.4B
| $36.2M | 0.18% |
156,355
-135,937
| -47% | -$31.5M |
|
103
Edwards Lifesciences
EW
$47.7B
| $36.1M | 0.18% |
+377,997
| New | +$36.1M |
|
104
Alphatec Holdings
ATEC
$2.35B
| $36.1M | 0.18% |
2,617,225
+386,134
| +17% | +$5.32M |
|
105
BlackLine
BL
$3.26B
| $36.1M | 0.18% |
558,762
-271,230
| -33% | -$17.5M |
|
106
Xometry
XMTR
$2.37B
| $36M | 0.18% |
2,129,871
+48,841
| +2% | +$825K |
|
107
CryoPort
CYRX
$426M
| $35.3M | 0.17% |
1,991,777
+2,381
| +0.1% | +$42.1K |
|
108
Blue Owl Capital
OWL
$11.7B
| $34.8M | 0.17% |
+1,844,128
| New | +$34.8M |
|
109
CoStar Group
CSGP
$37.2B
| $33.8M | 0.17% |
349,584
-12,776
| -4% | -$1.23M |
|
110
Akero Therapeutics
AKRO
$3.65B
| $33.8M | 0.17% |
1,336,881
+1,246,069
| +1,372% | +$31.5M |
|
111
Modine Manufacturing
MOD
$7.02B
| $33.5M | 0.17% |
+351,951
| New | +$33.5M |
|
112
MoonLake Immunotherapeutics
MLTX
$3.78B
| $33.5M | 0.17% |
666,722
-143,864
| -18% | -$7.23M |
|
113
Sarepta Therapeutics
SRPT
$1.98B
| $33.3M | 0.17% |
257,566
+167,231
| +185% | +$21.6M |
|
114
On Holding
ONON
$14.6B
| $33.2M | 0.16% |
939,126
+799,025
| +570% | +$28.3M |
|
115
AAR Corp
AIR
$2.72B
| $31.3M | 0.16% |
522,651
+207,369
| +66% | +$12.4M |
|
116
IBM
IBM
$227B
| $30.6M | 0.15% |
+160,449
| New | +$30.6M |
|
117
Flywire
FLYW
$1.61B
| $30.4M | 0.15% |
1,225,410
-201,818
| -14% | -$5.01M |
|
118
RXO
RXO
$2.62B
| $30.1M | 0.15% |
1,377,208
-24,139
| -2% | -$528K |
|
|
NVRO
119
DELISTED
NEVRO CORP.
NVRO
| $30.1M | 0.15% |
2,083,687
-35,579
| -2% | -$514K |
|
120
Ascendis Pharma
ASND
$12.1B
| $28.1M | 0.14% |
186,121
-7,381
| -4% | -$1.12M |
|
121
e.l.f. Beauty
ELF
$7.38B
| $27.8M | 0.14% |
142,062
-1,584
| -1% | -$311K |
|
122
BioLife Solutions
BLFS
$1.2B
| $27.6M | 0.14% |
1,490,298
-134,738
| -8% | -$2.5M |
|
123
Novanta
NOVT
$4.05B
| $27.4M | 0.14% |
156,683
-36,490
| -19% | -$6.38M |
|
124
Tenable Holdings
TENB
$3.72B
| $27.4M | 0.14% |
553,908
-39,465
| -7% | -$1.95M |
|
125
Ultragenyx Pharmaceutical
RARE
$3.04B
| $27.2M | 0.13% |
581,551
-22,425
| -4% | -$1.05M |
|